Beyond evidence: reappraising use of CA-125 as post-therapy surveillance for ovarian cancer

Med J Aust. 2012 Apr 16;196(7):440-1. doi: 10.5694/mja11.10889.
No abstract available

MeSH terms

  • Adaptation, Psychological
  • Biomarkers, Tumor / blood
  • CA-125 Antigen / blood*
  • Female
  • Humans
  • Ovarian Neoplasms / diagnosis*
  • Ovarian Neoplasms / drug therapy
  • Ovarian Neoplasms / mortality
  • Ovarian Neoplasms / psychology
  • Quality of Life

Substances

  • Biomarkers, Tumor
  • CA-125 Antigen